CURRENT CANCER STEM CELL BIOMARKERS IN TONGUE SQUAMOUS CELL CARCINOMA
Abstract
Tongue squamous cell carcinoma (TSCC) is known to be the most malignant
cancer type amongst other oral cancers with increasing incidence and mortality
rates in the past five years. Since the life expectancy for TSCC patients is
limited and the current chemo-radiotherapy treatments are not curative, novel
biomarkers are urgently needed. As many other solid tumors, TSCC has a heterogeneous
cancer cell population, which includes a small subpopulation identified as
cancer stem cells (CSCs) that are considered as the driving force for tumor
initiation, development, spread, recurrence, and resistance to
chemo-radiotherapy. Although the underlying molecular mechanisms of how CSCs
are involved in the carcinogenesis are not completely understood, scientists
and clinicians aim to utilize those cells as therapeutic tools in fight against
different cancer types including TSCC. Here, we reviewed and summarized
important findings and the most current literature to shed light on the
potential of cancer stem cells markers in TSCC. Possible functions of CSCs
biomarkers in TSCC pathogenesis during cancer initiation, progression, invasion
or metastasis are also summarized.
Keywords
References
- 1. Abrigo, M., Alvarez, R., Paparella, M.L., Calb, D.E., Bal de Kier Joffe, E., Gutkind, J.S. & Raimondi, A.R. (2014). Impairing squamous differentiation by Klf4 deletion is sufficient to initiate tongue carcinoma development upon K-Ras activation in mice. Carcinogenesis, 35(3): 662-669.
- 2. Alam, M., Kashyap, T., Pramanik, K.K., Singh, A.K., Nagini, S. & Mishra, R. (2017). The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance. Clinical Oral Investigations, 21(9): 2721-2731.
- 3. Baillie, R., Itinteang, T., Yu, H.H., Brasch, H.D., Davis, P.F. & Tan, S.T. (2016). Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma. Journal of Clinical Pathology, 69(8): 742-744.
- 4. Baillie, R., Tan, S.T. & Itinteang, T. (2017). Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review. Frontiers in Oncology, 7: 112.
- 5. Boldrup, L., Coates, P.J., Laurell, G., Wilms, T., Fahraeus, R. & Nylander, K. (2015). Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma. British Journal of Cancer, 112(11): 1760-1765.
- 6. Bourguignon, L.Y., Earle, C., Wong, G., Spevak, C.C. & Krueger, K. (2012). Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene, 31(2): 149-160.
- 7. Bourguignon, L.Y.W., Earle, C. & Shiina, M. (2017). Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. International Journal of Molecular Science, 18(9): 1849.
- 8. Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., Gifford, D.K., Melton, D.A., Jaenisch, R. & Young, R. A. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122(6): 947-956.
Details
Primary Language
English
Subjects
Structural Biology
Journal Section
Review
Authors
Omer Faruk Karatas
*
Türkiye
Seyma Teber
This is me
Ahmet Yilmaz
This is me
Asli Baltacioglu
This is me
Selinay Merve Kilic
This is me
Emel Poyraz
This is me
Abdulmelik Aytatli
This is me
Sumeyye Ozturk
This is me
Ayse Varol
This is me
Publication Date
October 15, 2018
Submission Date
December 19, 2017
Acceptance Date
June 3, 2018
Published in Issue
Year 2018 Volume: 19 Number: 2